20h
FOX 8 News on MSNToddler tower stools recalled after injuries to childrenMore than 10,000 toddler stools sold exclusively on Amazon are being recalled after reports of the stools collapsing or ...
The Trump administration is pausing over $175,000,000 in federal funding from the University of Pennsylvania (UPenn) over its policies conflicting ...
18h
The Everymom on MSNRecall Alerts: Do You Have Any of These Baby Products Sold on Amazon?Whenever anyone asks me for baby registry recommendations, I always have to be careful not to mention a baby product ...
A new study has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice, following from human studies.
A University of Cincinnati study found machine learning models can aid in the automation and detection of abnormal brain ...
A 22-year-old had a brain hemorrhage and died after riding a “fifth dimension” roller coaster with rotating seats at Six ...
20h
News Medical on MSNBrain dynamics during male sexual behavior revealedTo uncover what drives sexual behavior in animals, researchers studied the brain activity of male mice throughout the series of actions involved in sex leading up to ejaculation.
Scientists have recently detailed how automation and machine learning can aid clinicians treating patients with spreading depolarizations, sometimes referred to as 'brain tsunamis.' ...
It is a detailed view of the brain like never seen before. In a significant technological leap, University of Florida ...
Preparing for the NCAA Tournament is like drinking out of a firehose. We get 68 teams announced in a matter of minutes on ...
20h
News Medical on MSNPitt researchers develop a new way to profile pediatric brain tumorsResearchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh developed a new way to profile brain cancers in children, paving ...
Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results